ArticleNature2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
76 authors.
Ignacio MeleroClínica Universidad de Navarra, CIMA, IDISNA and CIBERONC, Pamplona, Spain. imelero@unav.es.ORCID http://orcid.org/0000-0002-1360-348X
Maria de Miguel LukenSTART Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
Guillermo de VelascoMedical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.
Elena GarraldaVall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4412-7842
Juan Martín-LiberalMedical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
Markus JoergerDepartment of Medical Oncology & Hematology, Cantonal Hospital, St Gallen, Switzerland.
Guzman AlonsoNEXT Oncology Phase I Unit/IOB - Hospital Quirónsalud Barcelona, Barcelona, Spain.
Maria-Elisabeth GoebelerMedizinische Klinik 2, Early Clinical Trial Unit, University Hospital Würzburg, Würzburg, Germany.
Martin SchulerWest German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.ORCID http://orcid.org/0000-0002-2166-3394
David KönigDepartment of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Reinhard DummerDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-2279-6906
Maria ReigInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) & Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain.
Maria-Esperanza Rodriguez RuizDepartment of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
Emiliano CalvoSTART Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.ORCID http://orcid.org/0000-0003-4921-829X
Jorge Esteban-VillarrubiaMedical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0002-2547-016X
Arjun OberoiVall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Paula SabatMedical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.ORCID http://orcid.org/0009-0003-1630-7453
Juan José Soto-CastilloMedical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.ORCID http://orcid.org/0000-0001-9630-4233
Kira-Lee KosterDepartment of Medical Oncology & Hematology, Cantonal Hospital, St Gallen, Switzerland.ORCID http://orcid.org/0000-0002-6549-8124
Omar SaavedraNEXT Oncology Phase I Unit/IOB - Hospital Quirónsalud Barcelona, Barcelona, Spain.
Cyrus SayehliMedizinische Klinik 2, Early Clinical Trial Unit, University Hospital Würzburg, Würzburg, Germany.
Tanja GromkeWest German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.ORCID http://orcid.org/0009-0005-1373-0840
Heinz LäubliDepartment of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Egle RamelyteDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Marta FortunyInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) & Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain.
Ana Landa-MagdalenaDepartment of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.ORCID http://orcid.org/0000-0001-9352-4329
Irene MorenoSTART Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.ORCID http://orcid.org/0000-0001-5027-6388
Javier Torres-JiménezMedical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0001-9023-4529
Alberto Hernando-CalvoVall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Dagmar HessDepartment of Medical Oncology & Hematology, Cantonal Hospital, St Gallen, Switzerland.
Fabricio RaccaNEXT Oncology Phase I Unit/IOB - Hospital Quirónsalud Barcelona, Barcelona, Spain.
Heike RichlyWest German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.
Andreas M SchmittDepartment of Medical Oncology, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9568-8164
Corinne EggenschwilerDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Marco Sanduzzi-ZamparelliInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) & Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain.
Anna Vilalta-LacarraDepartment of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.ORCID http://orcid.org/0000-0002-4787-5176
Jörg TrojanDepartment of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0001-9414-378X
Christine KochDepartment of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.
Peter R GalleDepartment of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Friedrich FoersterDepartment of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Zlatko TrajanoskiInstitute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-0636-7351
Hubert HacklInstitute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-4055-3841
Falk GogollaInstitute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0001-9329-0294
Florestan J KollDepartment of Urology, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0001-7828-3950
Peter WildSenckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Felix Kyoung Hwan ChunDepartment of Urology, Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany.
Henning ReisSenckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Peter LloydKinDyn Consulting, Warnham, UK.
Matthias MachacekLYO-X AG, Basel, Switzerland.ORCID http://orcid.org/0000-0003-0541-2365
Thomas F GajewskiThe University of Chicago Medical Center, Chicago, IL, USA.
Wolf H FridmanCentre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-1332-0973
Alexander M M EggermontUniversity Medical Center Utrecht and Princess Máxima Center, Utrecht, The Netherlands.
Ralf BargouComprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-1221-7421
Sandra SchönigerDiscovery Life Sciences Biomarker Services, Kassel, Germany.
Josef RüschoffDiscovery Life Sciences Biomarker Services, Kassel, Germany.
Anastasiia TereshchenkoDiscovery Life Sciences Biomarker Services, Kassel, Germany.
Carina ZinkMetronomia Clinical Research, Munich, Germany.
Antonio da Silvada Silva Consulting Services, Munich, Germany.
Felix S LichteneggerCatalYm, Munich, Germany.
Julia AkdemirCatalYm, Munich, Germany.
Manfred RüdigerCatalYm, Munich, Germany.
Phil L'HuillierCatalYm, Munich, Germany.
Aradhana DuttaCatalYm, Munich, Germany.
Markus HaakeCatalYm, Munich, Germany.ORCID http://orcid.org/0009-0008-3353-7919
Alexandra AuckenthalerCatalYm, Munich, Germany.
Ana GjorgjioskaCatalYm, Munich, Germany.ORCID http://orcid.org/0009-0002-0886-0841
Bernhard RösslerCatalYm, Munich, Germany.ORCID http://orcid.org/0009-0007-3347-4973
Frank HermannCatalYm, Munich, Germany.
Mara LiebigCatalYm, Munich, Germany.
Daniela ReichhardtCatalYm, Munich, Germany.
Christine Schuberth-WagnerCatalYm, Munich, Germany.
Jörg WischhusenDepartment of Gynecology, University Hospital Würzburg, Würzburg, Germany.
Petra FettesCatalYm, Munich, Germany.
Marlene AuerCatalYm, Munich, Germany.ORCID http://orcid.org/0009-0005-1770-413X
Kathrin KlarCatalYm, Munich, Germany.ORCID http://orcid.org/0000-0002-4808-8852
Eugen LeoCatalYm, Munich, Germany. eugen.leo@catalym.com.ORCID http://orcid.org/0009-0004-4480-9351
Funding
Overcoming resistance to anti-PD1 immunotherapyR35CA210098 · NCI · UNIVERSITY OF CHICAGO · PI THOMAS F GAJEWSKI · 2017 to 2026
$10.4MNCI NIH HHS R35 CA210098
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.